Related Experiment Video
Updated: Apr 19, 2026

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets
Published on: October 3, 2014
Tissue engineered scaffolds in regenerative medicine
Mohsen Hosseinkhani1, Davood Mehrabani2, Mohammad Hassan Karimfar3
1Department of Anatomical Sciences, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran;
Three-dimensional (3D) scaffolds enhance stem cell differentiation for tissue regeneration. Biodegradable materials combined with stem cell technologies show promise for engineered tissue replacements, particularly using bone marrow stem cells (BMSCs) and mesenchymal stem cells (MSCs).
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Stem Cell Biology
Background:
- Conventional 2D stem cell cultures lack in vivo microenvironment complexity.
- Three-dimensional (3D) in vitro models offer a promising approach to mimic native stem cell niches.
- Biodegradable scaffolds are crucial for creating 3D environments that promote tissue formation.
Purpose of the Study:
- To review the application of tissue-engineered scaffolds and stem cells for developing engineered tissue replacements.
- To highlight the potential of 3D in vitro models in stem cell differentiation and tissue regeneration.
- To focus on bone marrow stem cells (BMSCs) and mesenchymal stem cells (MSCs) for clinical applications.
Main Methods:
- Review of current literature on stem cell technologies and tissue engineering scaffolds.
- Analysis of the role of biodegradable scaffolds in creating 3D stem cell microenvironments.
- Focus on studies utilizing bone marrow stem cells (BMSCs) and mesenchymal stem cells (MSCs).
Main Results:
- Three-dimensional (3D) scaffolds significantly enhance stem cell differentiation and tissue formation compared to 2D cultures.
- The combination of biodegradable scaffolds and stem cell technologies holds substantial potential for tissue regeneration.
- Bone marrow stem cells (BMSCs) and mesenchymal stem cells (MSCs) are key cell types for engineered tissue replacements due to their clinical relevance.
Conclusions:
- Tissue-engineered scaffolds provide a viable strategy for mimicking in vivo conditions, promoting stem cell differentiation.
- The integration of stem cell technologies with biodegradable scaffolds is essential for advancing regenerative medicine.
- Further research into BMSCs and MSCs within 3D environments will drive the development of effective engineered tissue replacements.
More Related Videos
09:49Author Spotlight: Insights into the Use of Apple-Derived Cellulose Scaffolds for Bone Tissue Engineering
Published on: February 23, 2024
09:35Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect
Published on: September 11, 2015